Cocrystal Pharma, Inc.
Q4 2022 13F Holders
Symbol
COCP
CUSIP
19188J409
Type
Equity
Class
COM NEW
Num filers
22
Total reported value, excl. options
$2.12M
Compare 2022 Q4 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
Manager
Report Date
Value ($000)
Shares
Option Type